Hanesbrands stock surges, as potential sale of Champion business is being considered
Shares of Hanesbrands Inc. (HBI) jumped 2.2% in premarket trading Tuesday, after the clothes and underwear seller said it is considering a broad range of alternatives for its Champion athletic-apparel business, including a potential sale. The company said it has not set a timetable to complete its review of alternatives, and there is no assurance that the review will result in any transaction. "In recent years, the executive leadership team has implemented significant structural improvements within Champion that have resulted in greater distinction between the company's innerwear and activewear businesses," said Chairman Ronald Nelson. "With this in mind, and after careful consideration, we have commenced a comprehensive review of strategic options for the global Champion business." The stock has tumbled 29.9% year to date through Monday, while the S&P 500 has gained 16.0%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-19-23 0857ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters